60667-3 |
Palatal plane to mandibular plane |
Angle |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Palatal plane to mandibular plane [Angle] Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
deg |
|
|
|
|
|
|
DENTAL |
|
60667-3 |
|
XR.measured |
|
|
|
|
|
|
0 |
ANSPNS-GoGn Angle Skull XR |
|
|
|
N |
|
ANSPNS-GOGN; Cranial; Cranium; Dental; Dentistry; Go-Gn; gonion to gnathion; Head; Mand; Me-Goi; menton to reconstructed gonion; MP; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray |
2.4 |
2.34 |
|
|
|
|
|
|
|
deg |
|
|
|
0 |
60668-1 |
Palatal plane to mandibular plane constructed Gonion |
Angle |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Palatal plane to mandibular plane constructed Gonion [Angle] Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
deg |
|
|
|
|
|
|
DENTAL |
|
60668-1 |
|
XR.measured |
|
|
|
|
|
|
0 |
ANSPNS-GoGn (constructed) Angle Skull XR |
|
|
|
N |
|
ANSPNS-GOGN; ANSPNS-GoGn (constructed); Cranial; Cranium; Dental; Dentistry; Go-Gn; gonion to gnathion; Head; Mand; Me-Goi; menton to reconstructed gonion; MP; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray |
2.4 |
2.34 |
|
|
|
|
|
|
|
deg |
|
|
|
0 |
60669-9 |
Glabella to subnasale |
Len |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Glabella to subnasale [Length] Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
DENTAL |
|
60669-9 |
|
XR.measured |
|
|
|
|
|
|
0 |
Gl-Sn Skull XR |
|
|
|
N |
|
Cranial; Cranium; Dental; Dentistry; Eyebrows; G; Glabellar; GL-SN; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray |
2.34 |
2.34 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
6067-3 |
Cheese cheddar type Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Cheese cheddar type IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L; kU/L |
|
|
|
|
|
|
ALLERGY |
|
6067-3 |
|
|
|
|
Both |
|
|
|
0 |
Cheddar IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f081; f81; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0d |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
60670-7 |
Subnasale to menton |
Len |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Subnasale to menton [Length] Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
60670-7 |
|
XR.measured |
|
|
|
|
|
|
0 |
Sn-Me Skull XR |
|
|
|
N |
|
Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SN-ME; Xray; X-ray |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
60671-5 |
Sella-nasion plane to nasion-pogonion line |
Angle |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Sella-nasion plane to nasion-pogonion line [Angle] Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
deg |
|
|
|
|
|
|
DENTAL |
|
60671-5 |
|
XR.measured |
|
|
|
|
|
|
0 |
SeNa-NaPg Angle Skull XR |
|
|
|
N |
|
Cranial; Cranium; Dental; Dentistry; Head; NP; NPg; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Se-Na; SENA-NAPG; S-N; Xray; X-ray |
2.4 |
2.34 |
|
|
|
|
|
|
|
deg |
|
|
|
0 |
60672-3 |
Upper lip thickness |
Len |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Upper lip thickness Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
DENTAL |
|
60672-3 |
|
XR.measured |
|
|
|
|
|
|
0 |
Ls-Sd Skull XR |
|
|
|
N |
|
Cranial; Cranium; Dental; Dentistry; Head; Length; LS-SD; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Up; Xray; X-ray |
2.34 |
2.34 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
60673-1 |
Soft tissue thickness at A-point |
Len |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Soft tissue thickness at A-point Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
DENTAL |
|
60673-1 |
|
XR.measured |
|
|
|
|
|
|
0 |
A-A' Skull XR |
|
|
|
N |
|
A-A'; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SS; Subspinale; Thick; Xray; X-ray |
2.34 |
2.34 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
60674-9 |
Nasion to A-point |
Len |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Nasion to A-point [Length] Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
DENTAL |
|
60674-9 |
|
XR.measured |
|
|
|
|
|
|
0 |
Na-A Skull XR |
|
|
|
N |
|
Cranial; Cranium; Dental; Dentistry; Head; Length; NA-A; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SS; Subspinale; Xray; X-ray |
2.34 |
2.34 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
60675-6 |
Mandibular body length |
Len |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Mandibular body length Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
DENTAL |
|
60675-6 |
|
XR.measured |
|
|
|
|
|
|
0 |
Go-Me Skull XR |
|
|
|
N |
|
bod; Bodies; Cranial; Cranium; Dental; Dentistry; Go-Me; Head; Len; Length; Mand; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray |
2.34 |
2.34 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
60676-4 |
Ethyl sulfate |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Ethyl sulfate [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
60676-4 |
|
|
|
|
Both |
|
|
|
0 |
Ethyl sulfate Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Ethanol metabolite; ethyl hydrogen sulfate; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid; UA; UR; Urn |
2.73 |
2.34 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
60677-2 |
Alpha hydroxytriazolam |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Alpha hydroxytriazolam [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
60677-2 |
|
|
|
|
Both |
|
|
|
0 |
A-OH-triazolam Ur-mCnc |
|
|
|
N |
|
1-hydroxytriazolam; Alfa; Alpha hydroxy triazolam; A-OH-triazolam; DRUG/TOXICOLOGY; Drugs; Hydroxy triazolam; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; UA; UR; Urn |
2.73 |
2.34 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
60678-0 |
Protein/Creatinine |
MRto |
Urine |
12H |
Qn |
|
|
ACTIVE |
Protein/Creatinine [Mass Ratio] in 12 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mg/g creatinine |
|
|
|
|
|
|
CHEM |
|
60678-0 |
|
|
|
|
Both |
|
|
|
0 |
Prot/Creat 12h Ur |
|
|
|
N |
|
12 hours; 12HR; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; PR; Prot; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn |
2.73 |
2.36 |
|
|
|
|
|
|
|
mg/g{creat} |
|
|
|
0 |
6068-1 |
Cheese mold type Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Cheese mold type IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L; kU/L |
|
|
|
|
|
|
ALLERGY |
|
6068-1 |
|
|
|
|
Both |
|
|
|
0 |
Cheese Mold IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f082; f82; Immune globulin E; Immunoglobulin E; Mould; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0d |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
60680-6 |
Cortisol.free^30M post dose corticotropin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol Free [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
CHAL |
|
60680-6 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis F 30M p ACTH SerPl-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; 30M p ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortis F; Cortrosyn; F; FR; hydrocortisone; Level; Mass concentration; Non-protein bound; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker |
2.73 |
2.34 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
60681-4 |
Cortisol.free^1H post dose corticotropin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol Free [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
CHAL |
|
60681-4 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis F 1h p ACTH SerPl-mCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 17-Hydroxycorticosterone; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortis F; Cortrosyn; F; FR; hydrocortisone; Level; Mass concentration; Non-protein bound; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker |
2.73 |
2.34 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
60682-2 |
Standardized allergenic |
- |
^FDA product label |
- |
Nar |
|
|
ACTIVE |
FDA product label Standardized allergenic |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOCUMENT.REGULATORY |
|
60682-2 |
|
|
|
|
|
|
|
|
0 |
FDA label Standardized allergenic |
|
|
|
N |
|
DOCUMENT.REGULATORY; FDA label; Narrative; Report |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
60683-0 |
Plasma derivative |
- |
^FDA product label |
- |
Nar |
|
|
ACTIVE |
FDA product label Plasma derivative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.REF |
|
60683-0 |
|
|
|
|
|
|
|
|
0 |
FDA label Plasma derivative |
|
|
|
N |
|
DOCUMENT.REF; FDA label; Narrative; Report |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
60684-8 |
Cellular therapy |
- |
^FDA product label |
- |
Nar |
|
|
ACTIVE |
FDA product label Cellular therapy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.REF |
|
60684-8 |
|
|
|
|
|
|
|
|
0 |
FDA label Cellular therapy |
|
|
|
N |
|
DOCUMENT.REF; FDA label; Narrative; Report |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
60685-5 |
Indexing - pharmacologic class |
- |
^FDA package insert |
- |
Nar |
|
|
ACTIVE |
FDA package insert Indexing - pharmacologic class |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.REF |
|
60685-5 |
|
|
|
|
|
|
|
|
0 |
FDA insert Index - pharm class |
|
|
|
N |
|
DOCUMENT.REF; FDA insert; Index - pharm class; Narrative; Report; SPL; Structured Product Labelling |
2.34 |
2.34 |
|
|
|
|
|
|
|
|
|
|
|
0 |
60686-3 |
Overbite |
Len |
Skull |
Pt |
Qn |
XR.measured |
|
ACTIVE |
Overbite [Length] Skull X-ray measured |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
DENTAL |
|
60686-3 |
|
XR.measured |
|
|
|
|
|
|
0 |
Overbite Skull XR |
|
|
|
N |
|
Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray |
2.34 |
2.34 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
60687-1 |
Test of Infant Motor Performance Version 5.1 |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Test of Infant Motor Performance Version 5.1 |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 2001 IMPS, LLC. Authors: Suzann K. Campbell, Gay L. Girolami, Thubi, H. A. Kolobe, Elizabeth T. Osten, Maureen C. Lenke. All rights reserved. Used with permission. |
|
|
|
|
PANEL.TIMP |
|
60687-1 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Pan; Panel; PANEL.TIMP; Panl; Pnl; Point in time; Random; Test of Infant Motor Performance; TIMP |
2.5 |
2.34 |
|
Panel |
|
|
Copyright �© 2001 IMPS, LLC. Authors: Suzann K. Campbell, Gay L. Girolami, Thubi, H. A. Kolobe, Elizabeth T. Osten, Maureen C. Lenke. All rights reserved. Used with permission. |
|
|
|
|
|
|
0 |
60688-9 |
TIMP cover |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
TIMP cover |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 2001 IMPS, LLC. Authors: Suzann K. Campbell, Gay L. Girolami, Thubi, H. A. Kolobe, Elizabeth T. Osten, Maureen C. Lenke. All rights reserved. Used with permission. |
|
|
|
|
PANEL.TIMP |
|
60688-9 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Pan; Panel; PANEL.TIMP; Panl; Pnl; Point in time; Random; Test of Infant Motor Performance |
2.68 |
2.34 |
|
Organizer |
|
|
Copyright �© 2001 IMPS, LLC. Authors: Suzann K. Campbell, Gay L. Girolami, Thubi, H. A. Kolobe, Elizabeth T. Osten, Maureen C. Lenke. All rights reserved. Used with permission. |
|
|
|
|
|
|
0 |
60689-7 |
Observed items |
- |
^Patient |
Pt |
- |
TIMP |
|
ACTIVE |
Observed items [TIMP] |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 2001 IMPS, LLC. Authors: Suzann K. Campbell, Gay L. Girolami, Thubi, H. A. Kolobe, Elizabeth T. Osten, Maureen C. Lenke. All rights reserved. Used with permission. |
|
|
|
|
PANEL.TIMP |
|
60689-7 |
|
TIMP |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Pan; Panel; PANEL.TIMP; Panl; Pnl; Point in time; Random; Test of Infant Motor Performance |
2.68 |
2.34 |
|
Organizer |
|
|
Copyright �© 2001 IMPS, LLC. Authors: Suzann K. Campbell, Gay L. Girolami, Thubi, H. A. Kolobe, Elizabeth T. Osten, Maureen C. Lenke. All rights reserved. Used with permission. |
|
|
|
|
|
|
0 |
6069-9 |
Castanea sativa pollen Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Chestnut Pollen IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
6069-9 |
|
|
|
|
Both |
|
|
|
0 |
Chestnut Poln IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chestnut; Chestnut Poln; European chestnut; f299; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt206; Serum; SR; Sweet chestnut; t206 |
2.73 |
1.0d |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |